Kolexia
Adenis Antoine Médecine générale
Adenis Antoine
Médecine générale
Centre Hospitalier de Cayenne
Cayenne, France
295 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Histoplasmose Tumeurs de l'oesophage Adénocarcinome Infections à VIH Tumeurs colorectales Carcinomes Métastase tumorale Carcinome épidermoïde Infections opportunistes liées au SIDA

Collaborateurs

Voir plus
Nacher Mathieu
Nacher Mathieu
Centre Hospitalier de Cayenne, Cayenne, France
Couppie Pierre
Couppie Pierre
Centre Hospitalier de Cayenne, Cayenne, France
Pierre Demar Magalie
Pierre Demar Magalie
Centre Hospitalier de Cayenne, Cayenne, France
Djossou Felix
Djossou Felix
Centre Hospitalier de Cayenne, Cayenne, France

Industries

Voir plus
Sanofi
1 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975): A Randomized, Double-blind, Placebo-controlled Phase 3 Trial of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Receiving Concurrent Definitive Chemoradiotherapy (KEYNOTE 975)
Essai Clinique (Merck & Co.)   20 mars 2024
PROTECT: PReoperative Chemoradiation With Paclitaxel-carboplatin or With Fluorouracil-oxaliplatine-acide Folinique (FOLFOX) for Resectable Esophageal and Junctional Cancer - A Randomized Phase II Trial
Essai Clinique (Centre Oscar-Lambret)   26 février 2024
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS: Efficacy and Safety of High-dose Liposomal Amphotericin B (10 mg/kg) for Disseminated Histoplasmosis in AIDS: a Randomized Phase III Trial (INDUCTION Trial)
Essai Clinique (Federal University of Health Science of Porto Alegre)   20 février 2024
ChatGPT does not neglect a neglected disease, if appropriately prompted - Authors' reply.
The Lancet. Infectious diseases   12 février 2024
FOLFIRINOX-R: Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With RAS-mutated Metastatic Colorectal Cancer: a Dose-escalation, Phase I/II Trial
Essai Clinique (Institut du Cancer de Montpellier)   08 février 2024
CUREMA: Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield
Essai Clinique (Centre Hospitalier de Cayenne)   16 janvier 2024
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   16 janvier 2024
Contrasted life trajectories: reconstituting the main population exposomes in French Guiana.
Frontiers in public health   11 janvier 2024
ChatGPT neglects a neglected disease.
The Lancet. Infectious diseases   08 janvier 2024
Thirty years of HIV pregnancies in French Guiana: prevention successes and remaining obstetrical challenges.
Frontiers in global women's health   03 janvier 2024